Blog

Sep 21, 2024, 09:22

Karl Balabanian to visit Armenia for Collaborative Engagements in Immunotherapy and Oncology Research – Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn:

”Great news!

We are excited to share that this October, Dr. Karl Balabanian, Research Director at INSERM and leader of the ‘Chemokines, Lymphoid Niches and Immunopathology’ team at Saint-Louis Hospital and the INSERM U1160 unit, will be visiting Armenia. During his visit, he will engage with the teams at the Immune Oncology Research Institute and the Yeolyan Hematology and Oncology Center.”

Read further.
Source: Immune Oncology Research Institute/LinkedIn

cancer Cancer research Immune Oncology Research Institute Inserm INSERM U1160 unit Karl Balabanian OncoDaily Oncology Saint-Louis Hospital Yeolyan Hematology and Oncology Center

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage